Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    Here are the Hefty Fiscal Cliff Automatic Spending Cuts

    While much of the fiscal cliff debate has focused on possible tax increases, failure to reach a deal to avert the cliff could bring massive automatic spending cuts.

    Barring an agreement between U.S. President Barack Obama and Congress, $1.2 trillion of spending cuts over the coming decade would begin taking effect Jan. 2.

    The automatic spending cuts, known as "sequestration" - a result of Congress's 2011 negotiations to raise the debt ceiling - would total $109 billion in 2013, CBS News reported.

    Here's a closer look at where the cuts would be targeted.

    To continue reading, please click here...


    Read More...
  • fiscal cliff automatic spending cuts